Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Technologies Settles Junk DNA Patent Suit with Nuvelo and Covance, but not Applera

NEW YORK, Nov. 18 (GenomeWeb News) - Genetic Technologies of Melbourne, Australia, said today that it has settled lawsuits filed against Nuvelo and Covance for infringement of its non-coding DNA patents.

Genetic Technologies initiated legal action against the two companies and Applera in April 2003.

In a statement today, the company said it "will now dismiss the actions against Nuvelo and Covance," and "plans to "focus its efforts on the remaining action against Applera Corporation."

Specific terms of the settlements were not provided.

The company said it also plans to continue "global expansion of the out-licensing of the GTG non-coding patents" - a controversial strategy that has drawn criticism from the scientific community over the past year.

Genetic Technologies has claimed to be in negotiations with 60 potential licensees worldwide. Licensees and cross-licensees for the company's patents include Orchid Biosciences, Pyrosequencing, Nanogen, and Myriad.  

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more